APPLY NOW
Please note that this free pass is limited to active researchers
from pharmaceutical companies, biotech organisations,
research centres, academic institutes and CROs.
Applications will only be accepted with a company
email address
This agenda focuses on the latest innovation in vaccine development, with highlights including mRNA, nucleic acid vaccines, HIV, bioinformatics, and COVID-19. Sessions are a combination of panels, presentations, roundtables and case studies.
With an unprecedented acceleration in vaccine development seen over the past two years, the spotlight is now focused on the next generation of vaccines.
Drug Target Review‘s online summit covers all the latest innovation in vaccine development, exploring experimental delivery platforms, the most promising vaccine targets and novel early research on how to potentially protect against and treat conditions such as cancer and COVID-19.
In this two-day virtual event, covering both the early R&D and pre-clinical phase, leading scientists and experts from global pharmaceutical companies, biotech organisations, contact research organisations (CROs) and academic institutes presented their research and answered your most pressing questions about how vaccine development is moving towards a new frontier, bringing transformative prophylactics and treatments to patients.
*LIMITED FREE PASSES AVAILABLE: If you’re an active researcher from a pharmaceutical company, biotech organisation, research centre, academic institute or CRO, apply for your free pass now.
Gain access to an exciting and topical combination of keynotes, panel sessions, webinars, case studies and roundtable sessions.
Connect with all your fellow attendees and potential new partners through our dedicated online meetings platform and networking sessions.
Instant access to industry professions, new developments and interact in real-time.
Join experts for interactive product demonstrations, Q&As and in-depth analysis.
To see the type of attendees you can meet and network with at our events, view our 2022 attendee list below.
In 2021, over 600 scientists, researchers and experts from across the globe from pharmaceutical companies, biotech organisations, CROs and academic institutes explored innovation in cell and gene therapy.
Watch all presentations / sessions live and on-demand,
contact and network with all the attendees and speakers,
send messages and schedule meetings.
Please note that this free pass is limited to active researchers
from pharmaceutical companies, biotech organisations,
research centres, academic institutes and CROs.
Applications will only be accepted with a company
email address
Watch all presentations / sessions live and on-demand,
contact and network with all the attendees and speakers,
send messages and schedule meetings.
This pass is applicable to suppliers, consultants, VCs, lawyers, etc., who DO NOT fit the free pass criteria.
*ex VAT where applicable
Access speaking opportunities to position your brand as a thought leader, generate qualified leads, create brand awareness and receive detailed analytics. We commit to providing you full onboarding and support, as well as helping you deliver ROI.
If you are part of a pharmaceutical company, biotech organisation, CRO or an academic institute you can watch this on-demand online summit for FREE. Don't miss out accessing the latest research in vaccine platforms and delivery systems, immunology, vaccine targets and immuno-oncology.
© Copyright 2023 Russell Publishing Limited.
All Rights Reserved.
Registered address: Court Lodge, Hogtrough Hill, Brasted, Kent, TN16 1NU, United Kingdom
Company registration number: 2709148
+44 (0)1959 563 311
[email protected]
Access the latest news, articles, interviews and insights at Drug Target Review.
